MENU
+Compare
STXS
Stock ticker: ASE
AS OF
Nov 13 closing price
Price
$2.24
Change
-$0.19 (-7.82%)
Capitalization
209.05M

STXS Stereotaxis Forecast, Technical & Fundamental Analysis

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures... Show more

STXS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for STXS with price predictions
Nov 13, 2025

STXS's Stochastic Oscillator slumps into oversold zone

The Stochastic Oscillator for STXS moved into oversold territory on November 13, 2025. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where STXS advanced for three days, in of 230 cases, the price rose further within the following month. The odds of a continued upward trend are .

STXS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on STXS as a result. In of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for STXS turned negative on October 13, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

STXS moved below its 50-day moving average on October 29, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for STXS crossed bearishly below the 50-day moving average on November 04, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STXS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for STXS entered a downward trend on November 13, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. STXS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: STXS's P/B Ratio (142.857) is very high in comparison to the industry average of (10.086). P/E Ratio (0.000) is within average values for comparable stocks, (153.436). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.600). STXS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (6.135) is also within normal values, averaging (110.982).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STXS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
STXS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

STXS is expected to report earnings to fall 28.57% to -5 cents per share on February 27

Stereotaxis STXS Stock Earnings Reports
Q4'25
Est.
$-0.05
Q3'25
Missed
by $0.01
Q2'25
Beat
by $0.02
Q1'25
Est.
$-0.07
Q4'24
Missed
by $0.03
The last earnings report on November 11 showed earnings per share of -7 cents, missing the estimate of -5 cents. With 1.18M shares outstanding, the current market capitalization sits at 209.05M.
A.I. Advisor
published General Information

General Information

a designer of robotic cardiology instrument navigation systems

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
710 North Tucker Boulevard
Phone
+1 314 678-6100
Employees
122
Web
https://www.stereotaxis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WNMLA4.950.20
+4.21%
Winmill & Co. Incorporated
DSKIF24.00N/A
N/A
Daiseki Co., Ltd.
PTBS19.31N/A
N/A
Potomac Bancshares, Inc.
AMADY78.59-0.03
-0.04%
Amadeus IT Group SA
AHEXY16.09-0.15
-0.92%
Adecco Group AG

STXS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, STXS has been loosely correlated with SMTI. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if STXS jumps, then SMTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STXS
1D Price
Change %
STXS100%
-14.74%
SMTI - STXS
39%
Loosely correlated
-24.71%
TWST - STXS
36%
Loosely correlated
+1.76%
CERS - STXS
35%
Loosely correlated
N/A
BLFS - STXS
34%
Loosely correlated
-0.46%
NVST - STXS
33%
Loosely correlated
-0.45%
More

Groups containing STXS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STXS
1D Price
Change %
STXS100%
-14.74%
Pharmaceuticals
category (378 stocks)
32%
Poorly correlated
-0.99%
Pharmaceuticals: Other
category (103 stocks)
30%
Poorly correlated
-1.40%